Cargando…

Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo

We carried out adoptive transfer studies to determine the role of natural killer (NK) cells in resistance to murine cytomegalovirus (MCMV) and lymphocytic choriomeningitis virus (LCMV). We transferred leukocytes from adult mice into suckling mice 1 d before injecting them with virus. Resistance was...

Descripción completa

Detalles Bibliográficos
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 1985
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2187554/ https://www.ncbi.nlm.nih.gov/pubmed/2981954

Ejemplares similares

Natural killer cells in antiviral immunity
por: Björkström, Niklas K., et al.
Publicado: (2021)

Natural killer cells in antitumour adoptive cell immunotherapy
por: Laskowski, Tamara J., et al.
Publicado: (2022)

Roles of natural killer cells in antiviral immunity
por: Waggoner, Stephen N, et al.
Publicado: (2016)

Targeting of CXCR3 improves anti-myeloma efficacy of adoptively transferred activated natural killer cells
por: Bonanni, Valentina, et al.
Publicado: (2019)

Adoptive Natural Killer Cell Immunotherapy for Canine Osteosarcoma
por: Kisseberth, William C., et al.
Publicado: (2021)

Licensing Natural Killers for Antiviral Immunity
por: Cronk, John M., et al.
Publicado: (2021)

Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
por: Lupo, Kyle B., et al.
Publicado: (2019)

Natural killer cells act as rheostats modulating antiviral T cells
por: Waggoner, Stephen N., et al.
Publicado: (2011)

Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases
Publicado: (1991)

Leveraging Natural Killer Cell Innate Immunity against Hematologic Malignancies: From Stem Cell Transplant to Adoptive Transfer and Beyond
por: Lin, Chenyu, et al.
Publicado: (2022)

Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma
por: Tong, Alexander A., et al.
Publicado: (2017)

Editorial: Natural killer cell plasticity and diversity in antiviral immunity
por: Krebs, Philippe, et al.
Publicado: (2023)

Natural Killer Cells: A Promising Kit in the Adoptive Cell Therapy Toolbox
por: Xiao, Jiani, et al.
Publicado: (2022)

Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies
por: Matosevic, Sandro
Publicado: (2018)

Adoptive Transfer of Autologous Invariant Natural Killer T Cells as Immunotherapy for Advanced Hepatocellular Carcinoma: A Phase I Clinical Trial
por: Gao, Yao, et al.
Publicado: (2021)

Bortezomib Treatment to Potentiate the Anti-tumor Immunity of Ex-vivo Expanded Adoptively Infused Autologous Natural Killer Cells
por: Lundqvist, Andreas, et al.
Publicado: (2011)

Neonatal Natural Killer Cell Function: Relevance to Antiviral Immune Defense
por: Lee, Yen-Chang, et al.
Publicado: (2013)

Elimination In Vivo of Developing T Cells by Natural Killer Cells
por: Schott, Eckart, et al.
Publicado: (2003)

Bortezomib sensitizes human glioblastoma stem cells to adoptive natural killer cell cytotoxicity
por: Grossenbacher, Steven, et al.
Publicado: (2015)

Fully automated expansion and activation of clinical-grade natural killer cells for adoptive immunotherapy
por: GRANZIN, MARKUS, et al.
Publicado: (2015)

Engineering of chimeric natural killer cell receptors to develop precision adoptive immunotherapies for cancer
por: Obajdin, J., et al.
Publicado: (2020)

A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia
por: Nguyen, Rosa, et al.
Publicado: (2019)

Nfil3-independent lineage maintenance and antiviral response of natural killer cells
por: Firth, Matthew A., et al.
Publicado: (2013)

ANTIVIRAL RESPONSE OF NATURAL KILLER CELLS IN EARLY STAGE OF COVID-19 PATIENTS
por: Lopes, IA, et al.
Publicado: (2021)

In Vivo Survival and Homeostatic Proliferation of Natural Killer Cells
por: Prlic, Martin, et al.
Publicado: (2003)

Regulation of sepsis-induced IFNγ upon natural killer cell or natural killer T cell depletion in vivo
por: Christaki, E, et al.
Publicado: (2012)

Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells
por: Wilhelm, Martin, et al.
Publicado: (2014)

Natural killer cells and natural killer T cells in Lyme arthritis
por: Katchar, Kia, et al.
Publicado: (2013)

Natural killer cells act as an extrinsic barrier for in vivo reprogramming
por: Melendez, Elena, et al.
Publicado: (2022)

Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2
Publicado: (1984)

Effect of Antiviral Therapy During Pregnancy on Natural Killer Cells in Pregnant Women With Chronic HBV Infection
por: Wang, Fuchuan, et al.
Publicado: (2022)

In vivo natural killer and natural killer T-cell depletion affects mortality in a murine pneumococcal pneumonia sepsis model
por: Christaki, E, et al.
Publicado: (2012)

Adoptive Cell Therapy of Melanoma with Cytokine-induced Killer Cells
por: Kim, Ji Sung, et al.
Publicado: (2015)

Prospects and Advances in Adoptive Natural Killer Cell Therapy for Unmet Therapeutic Needs in Pediatric Bone Sarcomas
por: Bareke, Halin, et al.
Publicado: (2023)

Natural killer cells modified with a Gpc3 aptamer enhance adoptive immunotherapy for hepatocellular carcinoma
por: Zheng, Youshi, et al.
Publicado: (2023)

Enhancement of the Anticancer Ability of Natural Killer Cells through Allogeneic Mitochondrial Transfer
por: Kim, Seong-Hoon, et al.
Publicado: (2023)

Evidence for discrete stages of human natural killer cell differentiation in vivo
por: Freud, Aharon G., et al.
Publicado: (2006)

Interleukin 2-induced proliferation of murine natural killer cells in vivo
Publicado: (1990)

Ascophyllan Induces Activation of Natural Killer Cells in Mice In Vivo and In Vitro
por: Zhang, Wei, et al.
Publicado: (2019)

Alloreactive Natural Killer Cells for the Treatment of Acute Myeloid Leukemia: From Stem Cell Transplantation to Adoptive Immunotherapy
por: Ruggeri, Loredana, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qsadgn8j3meduv0e7g4oimlce4